Form4insider filings, from the source

SEC Form 4 · accession 0001127602-16-044366

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Alan J Main
Officer — EVP, CMC and Supply Operations
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 8:46 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 29, 2016M2,500—A29,647D
Common StockF1Feb 29, 2016M2,357—A32,004D
Common StockF1Feb 29, 2016M2,679—A34,683D
Common StockF1Feb 29, 2016M5,271—A39,954D
Common StockFeb 29, 2016F4,754$9.07D35,200D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock Units (Phantom Stock)F1,F3—Feb 29, 2016M2,500D——Common Stock2,5000D
Restricted Stock Units (Phantom Stock)F1,F4—Feb 29, 2016M2,357D——Common Stock2,3572,357D
Restricted Stock Units (Phantom Stock)F1,F5—Feb 29, 2016M2,679D——Common Stock2,6795,357D
Restricted Stock Units (Phantom Stock)F1,F6—Feb 29, 2016M5,271D——Common Stock5,27115,814D

Explanation of responses